全文获取类型
收费全文 | 1491篇 |
免费 | 122篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 23篇 |
妇产科学 | 14篇 |
基础医学 | 222篇 |
口腔科学 | 8篇 |
临床医学 | 129篇 |
内科学 | 294篇 |
皮肤病学 | 20篇 |
神经病学 | 180篇 |
特种医学 | 72篇 |
外科学 | 272篇 |
综合类 | 15篇 |
一般理论 | 2篇 |
预防医学 | 60篇 |
眼科学 | 14篇 |
药学 | 124篇 |
中国医学 | 8篇 |
肿瘤学 | 135篇 |
出版年
2024年 | 4篇 |
2023年 | 23篇 |
2022年 | 35篇 |
2021年 | 77篇 |
2020年 | 38篇 |
2019年 | 61篇 |
2018年 | 70篇 |
2017年 | 48篇 |
2016年 | 49篇 |
2015年 | 47篇 |
2014年 | 74篇 |
2013年 | 95篇 |
2012年 | 148篇 |
2011年 | 110篇 |
2010年 | 63篇 |
2009年 | 81篇 |
2008年 | 103篇 |
2007年 | 101篇 |
2006年 | 94篇 |
2005年 | 67篇 |
2004年 | 62篇 |
2003年 | 55篇 |
2002年 | 45篇 |
2001年 | 13篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 8篇 |
1997年 | 4篇 |
1996年 | 14篇 |
1995年 | 8篇 |
1994年 | 5篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有1624条查询结果,搜索用时 15 毫秒
41.
42.
Cyrille Thominiaux Béatrice de Bruin Yann Bramoullé Fran?oise Hinnen Stéphane Demphel Heric Valette Michel Bottlaender Laurent Besret Michael Kassiou Frédéric Dollé 《Applied radiation and isotopes》2006,64(3):348-354
Recently, a novel series of amidines has been described, exhibiting high NR2B-subtype selective N-methyl-D-aspartate (NMDA) antagonist activity with nanomolar or subnanomolar affinity. Within the styrylamidine subclass, (E)-N-(2-methoxybenzyl)-3-phenyl-acrylamidine (1), displayed the highest affinity (Ki=0.7 nM versus [(3)H]ifenprodil) and was considered an appropriate candidate for isotopic labelling with carbon-11 (T(1/2): 20.38 min) at its methoxy group for imaging of NMDA receptors with PET. Derivative 1 has been labelled from the corresponding nor-analogue using [(11)C]methyl triflate and the following experimental conditions : (1) trapping at -10 degrees C of [(11)C]methyl triflate in 300 microL of acetone containing 0.6-0.8 mg of precursor 5 (2.4-3.2 micromol) and 5 microL of a 3M solution of NaOH in water (about 5 eq.); (2) concentration to dryness of the reaction mixture (at 110 degrees C, using a helium stream for 1-2 min); (3) taking up the residue with 0.5 mL of the HPLC mobile phase and (4) purification using semi-preparative HPLC (SymmetryPrep) C-18, Waters, 300 x 7.8 mm). Typically, starting from a 1.5 Ci (55.5 GBq) [(11)C]CO(2) production batch, 120-240 m Ci (4.44-8.88 GBq) of [(11)C]-1 (20-40% decay-corrected radiochemical yield, n=5) was obtained within a total synthesis time of 25-30 min. Specific radioactivities ranged from 0.8 to 1.2 Ci/micromol (29.6-44.4 GBq/micromol) at the end of radiosynthesis. No attempts were made to further optimise these reactions, as sufficient material was obtained to allow for preliminary pharmacological characterisation. 相似文献
43.
Meyer PG Bonneville C Orliaguet GA Dessemme P Blakime P Carli PA Revillon Y 《Paediatric anaesthesia》2006,16(6):676-679
We report a case of hepatic hydatidosis where the first clinical manifestations, generalized seizures after minor head and abdominal trauma, and delayed anaphylaxis, made the primary diagnosis difficult. Severe anaphylaxis has been reported as initial presentation of quiescent hepatic hydatidosis. In endemic areas, the diagnosis must be carefully ruled out in patients experiencing abrupt anaphylactic shock of uncertain etiology. The occurrence of unexplained vascular collapse after minor abdominal trauma in a patient originating from an endemic area should prompt the diagnosis and urgent treatment should be initiated; firstly emergency management of the anaphylactic shock and later, surgical treatment of the cysts. 相似文献
44.
Laetitia Dard Christophe Hubert Pauline Esteves Wendy Blanchard Ghina Bou About Lyla Baldasseroni Elodie Dumon Chloe Angelini Mgane Delourme Vronique Guyonnet-Duprat Stphane Claverol Laura Fontenille Karima Kissa Pierre-Emmanuel Sgula Jean-Benoît Thambo Lvy Nicolas Yann Herault Nadge Bellance Nivea Dias Amoedo Frdrique Magdinier Tania Sorg Didier Lacombe Rodrigue Rossignol 《The Journal of clinical investigation》2022,132(8)
Germline mutations that activate genes in the canonical RAS/MAPK signaling pathway are responsible for rare human developmental disorders known as RASopathies. Here, we analyzed the molecular determinants of Costello syndrome (CS) using a mouse model expressing HRAS p.G12S, patient skin fibroblasts, hiPSC-derived human cardiomyocytes, a HRAS p.G12V zebrafish model, and human fibroblasts expressing lentiviral constructs carrying HRAS p.G12S or HRAS p.G12A mutations. The findings revealed alteration of mitochondrial proteostasis and defective oxidative phosphorylation in the heart and skeletal muscle of CS mice that were also found in the cell models of the disease. The underpinning mechanisms involved the inhibition of the AMPK signaling pathway by mutant forms of HRAS, leading to alteration of mitochondrial proteostasis and bioenergetics. Pharmacological activation of mitochondrial bioenergetics and quality control restored organelle function in HRAS p.G12A and p.G12S cell models, reduced left ventricle hypertrophy in CS mice, and diminished the occurrence of developmental defects in the CS zebrafish model. Collectively, these findings highlight the importance of mitochondrial proteostasis and bioenergetics in the pathophysiology of RASopathies and suggest that patients with CS may benefit from treatment with mitochondrial modulators. 相似文献
45.
Lagane B Ballet S Planchenault T Balabanian K Le Poul E Blanpain C Percherancier Y Staropoli I Vassart G Oppermann M Parmentier M Bachelerie F 《Molecular pharmacology》2005,67(6):1966-1976
CC chemokine receptor 5 (CCR5) is a G protein-coupled receptor that governs migration of leukocytes and serves as a coreceptor for the R5 tropic strains of human immunodeficiency virus (HIV). CCR5-mediated signaling in response to CC chemokines relies on G protein activation. Desensitization, which rapidly turns off G protein-dependent signaling, involves phosphorylation of CCR5 that promotes interaction of the receptor with beta-arrestins for endocytosis. Whether coupling to G proteins, desensitization, and endocytosis of CCR5 require the same structural determinants remains a matter of investigation. Here, we show that CCR5 displayed agonist-independent coupling to G proteins. This constitutive activity of the receptor was abrogated by TAK779 (N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride), a nonpeptidic CCR5 ligand that inhibits HIV infection and was found to depend on the integrity of the Asp-Arg-Tyr (DRY) motif. Changing Arg-126 by the neutral residue Asn (R126N-CCR5 mutant) abolished CCR5-mediated activation of G proteins, either constitutively or in response to agonists. In contrast, R126N-CCR5 not only retained agonist-promoted phosphorylation and beta-arrestin-dependent endocytosis but also displayed a higher basal phosphorylation than wild-type CCR5. Expression of beta-arrestin in R126N-CCR5-expressing cells resulted in receptor down-regulation, thereby suggesting that R126N-CCR5 spontaneously interacts with beta-arrestins. However, although expression of beta-arrestin favored wild-type CCR5-mediated chemotaxis, it failed to promote migration of cells expressing R126N-CCR5. Overall, these data indicate that structural requirements for CCR5-mediated activation of G proteins, albeit not involved in receptor desensitization and internalization, are needed for beta-arrestin-mediated chemotaxis. These results have implications for how distinct biological responses of CCR5 might rely on a different set of receptor conformations. 相似文献
46.
47.
Galanaud D Nicoli F Le Fur Y Roche P Confort-Gouny S Dufour H Ranjeva JP Peragut JC Viout P Cozzone PJ 《Annales de médecine interne》2002,153(8):491-498
Magnetic resonance spectroscopy (MRS) is a method enabling the analysis of the tissue metabolic content. It may offer a more accurate diagnosis of the intracranial tumors than conventional MRI sequences. MRS of normal brain parenchyma displays 4 main metabolites: N-acetyl aspartate (neuronal marker), creatine (cellular density marker), choline (membrane activity marker) and myoinositol (glial marker); pathological processes lead to variations of the level of these metabolites and/or the appearance of abnormal metabolites (lactate), following different patterns according to pathological process involved: glioma, meningioma, metastasis, bacterial or toxoplasmic abscess, radionecrosis. The potential clinical use of this method includes positive, differential and etiological diagnosis of tumors, determination of the level of malignancy of gliomas, screening for tumor recurrence following treatment. Our laboratory has been performing MR spectroscopic explorations of brain tumors for many years. Based on this experience, we show how MRS can be routinely performed in the clinical setting, what are its limitations and potential, and what kind of information can be supplied to the clinician. 相似文献
48.
49.
50.
Lenoir L Edeline J Rolland Y Pracht M Raoul JL Ardisson V Bourguet P Clément B Boucher E Garin E 《European journal of nuclear medicine and molecular imaging》2012,39(5):872-880